Ledger.Open graph →
SEC Form D · filed April 30, 2021

Adagio Therapeutics, Inc

Offering
$335.5M
Sold
$335.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Halley U. Gilbert · Waltham, MAExecTerrance U. Mcguire · Waltham, MADirectorRebecca U. Dabora · Waltham, MAExecRene U. Russo · Waltham, MADirectorHoward U. Mayer · Waltham, MADirectorPhilip U. Chase · Waltham, MADirectorEllie U. Hershberger · Waltham, MAExecAjay U. Royan · Waltham, MADirectorTillman U. Gerngross · Waltham, MAExec · DirectorLynn U. Connolly · Waltham, MAExecEric U. Kimble · Waltham, MAExecTillman U. Gerngross · Lebanon, NHExec · DirectorJane U. Henderson · Waltham, MAExecLaura U. Walker · Waltham, MAExecLynn U. Connolly · Waltham, MAExecEric U. Kimble · Waltham, MAExecHalley U. Gilbert · Waltham, MAExecTerrance U. Mcguire · Waltham, MADirectorRebecca U. Dabora · Waltham, MAExecRene U. Russo · Waltham, MADirectorHoward U. Mayer · Waltham, MADirectorPhilip U. Chase · Waltham, MADirectorEllie U. Hershberger · Waltham, MAExecAjay U. Royan · Waltham, MADirectorTillman U. Gerngross · Waltham, MAExec · DirectorJane U. Henderson · Waltham, MAExecLaura U. Walker · Waltham, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗